{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:37:22Z","timestamp":1791405442068,"version":"4.3.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12955-017-0713-x","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T07:49:44Z","timestamp":1499240984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Adherence to hydroxyurea, health-related quality of life domains, and patients\u2019 perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4739-265X","authenticated-orcid":false,"given":"Sherif M.","family":"Badawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Shei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Penedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Rychlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert I.","family":"Liem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,5]]},"reference":[{"key":"713_CR1","unstructured":"Sickle cell disease: data and statistics. \nhttp:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html\n\n. Accessed 15 Dec 2016."},{"key":"713_CR2","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376:2018\u201331.","journal-title":"Lancet"},{"key":"713_CR3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/pbc.24176","volume":"59","author":"JA Panepinto","year":"2012","unstructured":"Panepinto JA, Bonner M. Health-related quality of life in sickle cell disease: past, present, and future. Pediatr Blood Cancer. 2012;59:377\u201385.","journal-title":"Pediatr Blood Cancer"},{"key":"713_CR4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","volume":"312","author":"BP Yawn","year":"2014","unstructured":"Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312:1033\u201348.","journal-title":"JAMA"},{"key":"713_CR5","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","volume":"377","author":"WC Wang","year":"2011","unstructured":"Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377:1663\u201372.","journal-title":"Lancet"},{"key":"713_CR6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1542\/peds.2008-0441","volume":"122","author":"JJ Strouse","year":"2008","unstructured":"Strouse JJ, Lanzkron S, Beach MC, Haywood C, Park H, Witkop C, Wilson RF, Bass EB, Segal JB. Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics. 2008;122:1332\u201342.","journal-title":"Pediatrics"},{"key":"713_CR7","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1182\/blood-2012-03-419879","volume":"120","author":"CD Thornburg","year":"2012","unstructured":"Thornburg CD, Files BA, Luo Z, Miller ST, Kalpatthi R, Iyer R, Seaman P, Lebensburger J, Alvarez O, Thompson B, et al. Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood. 2012;120:4304\u201310. quiz 4448","journal-title":"Blood"},{"key":"713_CR8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MPH.0b013e3182114c54","volume":"33","author":"CD Thornburg","year":"2011","unstructured":"Thornburg CD, Calatroni A, Panepinto JA. Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea. J Pediatr Hematol Oncol. 2011;33:251\u20134.","journal-title":"J Pediatr Hematol Oncol"},{"key":"713_CR9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-7525-4-59","volume":"4","author":"SK Ballas","year":"2006","unstructured":"Ballas SK, Barton FB, Waclawiw MA, Swerdlow P, Eckman JR, Pegelow CH, Koshy M, Barton BA, Bonds DR. Hydroxyurea and sickle cell anemia: effect on quality of life. Health Qual Life Outcomes. 2006;4:59.","journal-title":"Health Qual Life Outcomes"},{"key":"713_CR10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1108\/IJHCQA-01-2013-0008","volume":"27","author":"E Nwenyi","year":"2014","unstructured":"Nwenyi E, Leafman J, Mathieson K, Ezeobah N. Differences in quality of life between pediatric sickle cell patients who used hydroxyurea and those who did not. Int J Health Care Qual Assur. 2014;27:468\u201381.","journal-title":"Int J Health Care Qual Assur"},{"key":"713_CR11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1542\/peds.2013-0333","volume":"132","author":"WC Wang","year":"2013","unstructured":"Wang WC, Oyeku SO, Luo Z, Boulet SL, Miller ST, Casella JF, Fish B, Thompson BW, Grosse SD, Investigators BH. Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia. Pediatrics. 2013;132:677\u201383.","journal-title":"Pediatrics"},{"key":"713_CR12","doi-asserted-by":"crossref","unstructured":"Badawy SM, Thompson AA, Lai JS, Penedo FJ, Rychlik K, Liem RI. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease. Pediatr Blood Cancer. 2016;64:e26369.","DOI":"10.1002\/pbc.26369"},{"key":"713_CR13","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1542\/peds.2014-0177","volume":"134","author":"KE Walsh","year":"2014","unstructured":"Walsh KE, Cutrona SL, Kavanagh PL, Crosby LE, Malone C, Lobner K, Bundy DG. Medication adherence among pediatric patients with sickle cell disease: a systematic review. Pediatrics. 2014;134:1175\u201383.","journal-title":"Pediatrics"},{"key":"713_CR14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jpeds.2009.09.044","volume":"156","author":"CD Thornburg","year":"2010","unstructured":"Thornburg CD, Calatroni A, Telen M, Kemper AR. Adherence to hydroxyurea therapy in children with sickle cell anemia. J Pediatr. 2010;156:415\u20139.","journal-title":"J Pediatr"},{"key":"713_CR15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/pbc.22605","volume":"55","author":"NG Patel","year":"2010","unstructured":"Patel NG, Lindsey T, Strunk RC, DeBaun MR. Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysis. Pediatr Blood Cancer. 2010;55:554\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"713_CR16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/jpepsy\/jsv084","volume":"41","author":"K Loiselle","year":"2016","unstructured":"Loiselle K, Lee JL, Szulczewski L, Drake S, Crosby LE, Pai AL. Systematic and meta-analytic review: medication adherence among pediatric patients with sickle cell disease. J Pediatr Psychol. 2016;41:406\u201318.","journal-title":"J Pediatr Psychol"},{"key":"713_CR17","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ajh.22101","volume":"86","author":"AM Brandow","year":"2011","unstructured":"Brandow AM, Panepinto JA. Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease. Am J Hematol. 2011;86:804\u20136.","journal-title":"Am J Hematol"},{"key":"713_CR18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1586\/ehm.10.22","volume":"3","author":"AM Brandow","year":"2010","unstructured":"Brandow AM, Panepinto JA. Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities. Expert Rev Hematol. 2010;3:255\u201360.","journal-title":"Expert Rev Hematol"},{"key":"713_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/02739610902813245","volume":"38","author":"AC Modi","year":"2009","unstructured":"Modi AC, Crosby LE. Barriers to treatment adherence for pediatric patients with sickle cell disease and their families. Children\u2019s Health Care. 2009;38:107\u201322.","journal-title":"Children\u2019s Health Care"},{"key":"713_CR20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/pbc.24381","volume":"60","author":"SO Oyeku","year":"2013","unstructured":"Oyeku SO, Driscoll MC, Cohen HW, Trachtman R, Pashankar F, Mullen C, Giardina PJ, Velazco N, Racine AD, Green NS. Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease. Pediatr Blood Cancer. 2013;60:653\u20138.","journal-title":"Pediatr Blood Cancer"},{"key":"713_CR21","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/pbc.25905","volume":"63","author":"SM Badawy","year":"2016","unstructured":"Badawy SM, Thompson AA, Liem RI. Technology access and Smartphone app preferences for medication adherence in adolescents and young adults with sickle cell disease. Pediatr Blood Cancer. 2016;63:848\u201352.","journal-title":"Pediatr Blood Cancer"},{"key":"713_CR22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajh.21883","volume":"86","author":"C Haywood Jr","year":"2011","unstructured":"Haywood C Jr, Beach MC, Bediako S, Carroll CP, Lattimer L, Jarrett D, Lanzkron S. Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease. Am J Hematol. 2011;86:85\u20137.","journal-title":"Am J Hematol"},{"issue":"6","key":"713_CR23","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/ejh.12878","volume":"98","author":"SM Badawy","year":"2017","unstructured":"Badawy SM, Thompson AA, Penedo FJ, Lai JS, Rychlik K, Liem RI. Barriers to Hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease. Eur J Haematol. 2017;98(6):608\u201314.","journal-title":"Eur J Haematol"},{"key":"713_CR24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.mph.0000193488.72989.c4","volume":"27","author":"JD Meyappan","year":"2005","unstructured":"Meyappan JD, Lampl M, Hsu LL. Parents\u2019 assessment of risk in sickle cell disease treatment with hydroxyurea. J Pediatr Hematol Oncol. 2005;27:644\u201350.","journal-title":"J Pediatr Hematol Oncol"},{"key":"713_CR25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s13104-015-1344-0","volume":"8","author":"S Creary","year":"2015","unstructured":"Creary S, Zickmund S, Ross D, Krishnamurti L, Bogen DL. Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision. BMC Res Notes. 2015;8:372.","journal-title":"BMC Res Notes"},{"key":"713_CR26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/MPH.0b013e3181f46884","volume":"33","author":"CA Patterson","year":"2011","unstructured":"Patterson CA, Barakat LP, Henderson PK, Nall F, Westin A, Dampier CD, Hsu LL. Comparing abstract numerical and visual depictions of risk in survey of parental assessment of risk in sickle cell hydroxyurea treatment. J Pediatr Hematol Oncol. 2011;33:4\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"713_CR27","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1080\/08870446.2015.1070851","volume":"30","author":"E Broadbent","year":"2015","unstructured":"Broadbent E, Wilkes C, Koschwanez H, Weinman J, Norton S, Petrie KJ. A systematic review and meta-analysis of the brief illness perception questionnaire. Psychol Health. 2015;30:1361\u201385.","journal-title":"Psychol Health"},{"key":"713_CR28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","volume":"60","author":"E Broadbent","year":"2006","unstructured":"Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60:631\u20137.","journal-title":"J Psychosom Res"},{"key":"713_CR29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12955-014-0160-x","volume":"12","author":"H Quinn","year":"2014","unstructured":"Quinn H, Thissen D, Liu Y, Magnus B, Lai JS, Amtmann D, Varni JW, Gross HE, DeWalt DA. Using item response theory to enrich and expand the PROMIS(R) pediatric self report banks. Health Qual Life Outcomes. 2014;12:160.","journal-title":"Health Qual Life Outcomes"},{"issue":"Suppl 1","key":"713_CR30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11136-007-9204-6","volume":"16","author":"D Cella","year":"2007","unstructured":"Cella D, Gershon R, Lai JS, Choi S. The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res. 2007;16(Suppl 1):133\u201341.","journal-title":"Qual Life Res"},{"key":"713_CR31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11136-009-9560-5","volume":"19","author":"SW Choi","year":"2010","unstructured":"Choi SW, Reise SP, Pilkonis PA, Hays RD, Cella D. Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms. Qual Life Res. 2010;19:125\u201336.","journal-title":"Qual Life Res"},{"key":"713_CR32","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, Amtmann D, Bode R, Buysse D, Choi S, et al. The patient-reported outcomes measurement information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63:1179\u201394.","journal-title":"J Clin Epidemiol"},{"key":"713_CR33","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s11136-013-0357-1","volume":"22","author":"JS Lai","year":"2013","unstructured":"Lai JS, Stucky BD, Thissen D, Varni JW, DeWitt EM, Irwin DE, Yeatts KB, DeWalt DA. Development and psychometric properties of the PROMIS((R)) pediatric fatigue item banks. Qual Life Res. 2013;22:2417\u201327.","journal-title":"Qual Life Res"},{"key":"713_CR34","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s11136-015-0953-3","volume":"24","author":"DA DeWalt","year":"2015","unstructured":"DeWalt DA, Gross HE, Gipson DS, Selewski DT, DeWitt EM, Dampier CD, Hinds PS, Huang IC, Thissen D, Varni JW. PROMIS((R)) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions. Qual Life Res. 2015;24:2195\u2013208.","journal-title":"Qual Life Res"},{"key":"713_CR35","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s11136-013-0544-0","volume":"23","author":"JW Varni","year":"2014","unstructured":"Varni JW, Magnus B, Stucky BD, Liu Y, Quinn H, Thissen D, Gross HE, Huang IC, DeWalt DA. Psychometric properties of the PROMIS (R) pediatric scales: precision, stability, and comparison of different scoring and administration options. Qual Life Res. 2014;23:1233\u201343.","journal-title":"Qual Life Res"},{"key":"713_CR36","doi-asserted-by":"crossref","unstructured":"Dampier C, Barry V, Gross HE, Lui Y, Thornburg CD, DeWalt DA, Reeve BB. Initial Evaluation of the Pediatric PROMIS(R) Health Domains in Children and Adolescents With Sickle Cell Disease. Pediatr Blood Cancer. 2016;63:1031\u20137.","DOI":"10.1002\/pbc.25944"},{"key":"713_CR37","doi-asserted-by":"crossref","unstructured":"Dampier C, Jaeger B, Gross HE, Barry V, Edwards L, Lui Y, DeWalt DA, Reeve BB. Responsiveness of PROMIS Pediatric Measures to Hospitalizations for Sickle Pain and Subsequent Recovery. Pediatr Blood Cancer. 2016;63:1038\u201345.","DOI":"10.1002\/pbc.25931"},{"key":"713_CR38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11136-010-9618-4","volume":"19","author":"DE Irwin","year":"2010","unstructured":"Irwin DE, Stucky BD, Thissen D, Dewitt EM, Lai JS, Yeatts K, Varni JW, DeWalt DA. Sampling plan and patient characteristics of the PROMIS pediatrics large-scale survey. Qual Life Res. 2010;19:585\u201394.","journal-title":"Qual Life Res"},{"key":"713_CR39","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","volume":"10","author":"DE Morisky","year":"2008","unstructured":"Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348\u201354.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"713_CR40","first-page":"59","volume":"15","author":"M Krousel-Wood","year":"2009","unstructured":"Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15:59\u201366.","journal-title":"Am J Manag Care"},{"key":"713_CR41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jpepsy\/27.5.475","volume":"27","author":"DE Logan","year":"2002","unstructured":"Logan DE, Radcliffe J, Smith-Whitley K. Parent factors and adolescent sickle cell disease: associations with patterns of health service use. J Pediatr Psychol. 2002;27:475\u201384.","journal-title":"J Pediatr Psychol"},{"key":"713_CR42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0009922806293985","volume":"46","author":"MJ Mitchell","year":"2007","unstructured":"Mitchell MJ, Lemanek K, Palermo TM, Crosby LE, Nichols A, Powers SW. Parent perspectives on pain management, coping, and family functioning in pediatric sickle cell disease. Clin Pediatr (Phila). 2007;46:311\u20139.","journal-title":"Clin Pediatr (Phila)"},{"key":"713_CR43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jpepsy\/jsi068","volume":"30","author":"M Connelly","year":"2005","unstructured":"Connelly M, Wagner JL, Brown RT, Rittle C, Cloues B, Taylor LC. Informant discrepancy in perceptions of sickle cell disease severity. J Pediatr Psychol. 2005;30:443\u20138.","journal-title":"J Pediatr Psychol"},{"key":"713_CR44","volume-title":"Issues in clinical child psychology","author":"M Rapoff","year":"2010","unstructured":"Rapoff M. Adherence to pediatric medical regimens. In: Issues in clinical child psychology. 2nd ed. New York: Springer Science+Business Media; 2010.","edition":"2nd"},{"key":"713_CR45","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1183\/09031936.00191511","volume":"40","author":"T Klok","year":"2012","unstructured":"Klok T, Kaptein AA, Duiverman EJ, Brand PL. High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs. Eur Respir J. 2012;40:1149\u201355.","journal-title":"Eur Respir J"},{"key":"713_CR46","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/TP.0b013e31824b822d","volume":"93","author":"M Kung","year":"2012","unstructured":"Kung M, Koschwanez HE, Painter L, Honeyman V, Broadbent E. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions. Transplantation. 2012;93:958\u201363.","journal-title":"Transplantation"},{"key":"713_CR47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jpepsy\/jsq027","volume":"35","author":"U Zugelj","year":"2010","unstructured":"Zugelj U, Zupancic M, Komidar L, Kenda R, Varda NM, Gregoric A. Self-reported adherence behavior in adolescent hypertensive patients: the role of illness representations and personality. J Pediatr Psychol. 2010;35:1049\u201360.","journal-title":"J Pediatr Psychol"},{"key":"713_CR48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2337\/dc10-1779","volume":"34","author":"E Broadbent","year":"2011","unstructured":"Broadbent E, Donkin L, Stroh JC. Illness and treatment perceptions are associated with adherence to medications, diet, and exercise in diabetic patients. Diabetes Care. 2011;34:338\u201340.","journal-title":"Diabetes Care"},{"key":"713_CR49","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/pbc.20903","volume":"48","author":"J Hankins","year":"2007","unstructured":"Hankins J, Hinds P, Day S, Carroll Y, Li CS, Garvie P, Wang W. Therapy preference and decision-making among patients with severe sickle cell anemia and their families. Pediatr Blood Cancer. 2007;48:705\u201310.","journal-title":"Pediatr Blood Cancer"},{"key":"713_CR50","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jpeds.2009.11.008","volume":"156","author":"LM Ingerski","year":"2010","unstructured":"Ingerski LM, Modi AC, Hood KK, Pai AL, Zeller M, Piazza-Waggoner C, Driscoll KA, Rothenberg ME, Franciosi J, Hommel KA. Health-related quality of life across pediatric chronic conditions. J Pediatr. 2010;156:639\u201344.","journal-title":"J Pediatr"},{"key":"713_CR51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1017\/S1047951114002728","volume":"26","author":"CE O\u2019Donovan","year":"2016","unstructured":"O\u2019Donovan CE, Painter L, Lowe B, Robinson H, Broadbent E. The impact of illness perceptions and disease severity on quality of life in congenital heart disease. Cardiol Young. 2016;26:100\u20139.","journal-title":"Cardiol Young"},{"issue":"7","key":"713_CR52","first-page":"3127","volume":"24","author":"J Vetsch","year":"2016","unstructured":"Vetsch J, Rueegg CS, Mader L, Bergstraesser E, Rischewski J, Kuehni CE, Michel G, Swiss Paediatric Oncology G. Follow-up care of young childhood cancer survivors: attendance and parental involvement. Support Care Cancer. 2016;24(7):3127\u201338.","journal-title":"Support Care Cancer"},{"key":"713_CR53","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/INF.0b013e31816dd325","volume":"27","author":"RC Vreeman","year":"2008","unstructured":"Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J. 2008;27:686\u201391.","journal-title":"Pediatr Infect Dis J"},{"key":"713_CR54","doi-asserted-by":"crossref","first-page":"e0141386","DOI":"10.1371\/journal.pone.0141386","volume":"10","author":"L Wisting","year":"2015","unstructured":"Wisting L, Bang L, Skrivarhaug T, Dahl-Jorgensen K, Ro O. Adolescents with type 1 diabetes--the impact of gender, age, and health-related functioning on eating disorder psychopathology. PLoS One. 2015;10:e0141386.","journal-title":"PLoS One"},{"key":"713_CR55","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.2196\/mhealth.7798","volume":"5","author":"SM Badawy","year":"2017","unstructured":"Badawy SM, Barrera L, Sinno MG, Kaviany S, O\u2019Dwyer LC, Kuhns LM. Text messaging and mobile phone apps as interventions to improve adherence in adolescents with chronic health conditions: a systematic review. JMIR Mhealth Uhealth. 2017;5:e66.","journal-title":"JMIR Mhealth Uhealth"},{"key":"713_CR56","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.2196\/mhealth.6837","volume":"5","author":"SM Badawy","year":"2017","unstructured":"Badawy SM, Kuhns LM. Texting and mobile phone app interventions for improving adherence to preventive behavior in adolescents: a systematic review. JMIR Mhealth Uhealth. 2017;5:e50.","journal-title":"JMIR Mhealth Uhealth"},{"key":"713_CR57","unstructured":"Teens, Social Media & Technology Overview 2015. \nhttp:\/\/www.pewinternet.org\/2015\/04\/09\/teens-social-media-technology-2015\/\n\n. Accessed 2 Jan 2017."},{"key":"713_CR58","unstructured":"U.S. Smartphone Use in 2015. \nhttp:\/\/www.pewinternet.org\/2015\/04\/01\/us-smartphone-use-in-2015\/\n\n. Accessed 2 Jan 2017."}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-017-0713-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T07:50:04Z","timestamp":1499241004000},"score":1,"resource":{"primary":{"URL":"http:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-017-0713-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,5]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["713"],"URL":"https:\/\/doi.org\/10.1186\/s12955-017-0713-x","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,5]]},"article-number":"136"}}